ArticleCancer management and research2021

Activation of FXR Suppresses Esophageal Squamous Cell Carcinoma Through Antagonizing ERK1/2 Signaling Pathway.

Qingqing Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.